Erratum: Sensitivity to biases of case-control studies on medical procedures, particularly surgery and blood transfusion, and risk of Creutzfeldt-Jakob disease (Neuroepidemiology 2012;39: (1-18)) DOI: 10.1159/000339318;Sensitivity to biases of case-control studies on medical procedures, particularly surgery and blood transfusion, and risk of creutzfeldt-jakob disease

Neuroepidemiology

Volumn 39, Issue 1, 2012, Pages 1-18

  De Pedro Cuesta, Jess ^a   Ruiz Tovar, Mara ^a   Ward, Hester ^d   Calero, Miguel ^b   Smith, Andrew ^f   Verduras, Concepcin Alonso ^c   Pocchiari, Maurizio ^g   Turner, Marc L ^d   Forland, Frode ^h,i   Palm, Daniel ^h   Will, Robert G ^e  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c Alternate Representative of Spain in EMA Management Board   (Spain)

^d SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^e WESTERN GENERAL HOSPITAL   (United Kingdom)

^f GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^g ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^h EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

ⁱ ROYAL TROPICAL INSTITUTE   (Netherlands)

Author keywords

Creutzfeldt Jakob disease; Epidemiological studies; Etiology; Latency analysis

Indexed keywords

BLOOD TRANSFUSION; CASE CONTROL STUDY; COHORT ANALYSIS; CREUTZFELDT JAKOB DISEASE; DENTAL SURGERY; EMBASE; ENDOSCOPIC SURGERY; HUMAN; MEDICAL PROCEDURES; MEDLINE; REVIEW; SENSITIVITY ANALYSIS; SPORADIC CREUTZFELDT JAKOB DISEASE; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; VALIDITY; VARIANT CREUTZFELDT JAKOB DISEASE;

EID: 84863522268     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000442357     Document Type: Erratum

References (52)

1. Prusiner SB: The prion diseases. Brain Pathol 1998; 8: 499-513. (Pubitemid 28308848)
2. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, et al: Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997; 389: 498-501. (Pubitemid 27435325)
3. Hewitt PE, Llewelyn CA, Mackenzie J, Will RG: Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang 2006; 91: 221-230. (Pubitemid 44337279)
4. Ward HJ, Everington D, Cousens SN, Smith-Bathgate B, Leitch M, Cooper S, et al: Risk factors for variant Creutzfeldt-Jakob disease: a case-control study. Ann Neurol 2006; 59: 111-120. (Pubitemid 43042877)
5. Everington D, Smith AJ, Ward HJ, Letters S, Will RG, Bagg J: Dental treatment and risk of variant CJD -a case control study. Br Dent J 2007; 202:E19, discussion 470-471.
6. Riggs JE, Moudgil SS, Hobbs GR: Creutzfeldt-Jakob disease and blood transfusions: a meta-analysis of case-control studies. Mil Med 2001; 166: 1057-1058. (Pubitemid 34015283)
7. Barash JA, Johnson BT, Gregorio DI: Is surgery a risk factor for Creutzfeldt-Jakob disease? Outcome variation by control choice and exposure assessments. Infect Control Hosp Epidemiol 2008; 29: 212-218. (Pubitemid 351269186)
8. de Pedro-Cuesta J, Bleda J, Rabano A, Cruz M, Laursen H, Molbak K, et al: Classification of surgical procedures for epidemiologic assessment of sporadic Creutzfeldt-Jakob disease transmission by surgery. Eur J Epidemiol 2006; 21: 595-604. (Pubitemid 44546621)
9. Mahillo-Fernandez I, de Pedro-Cuesta J, Bleda J, Cruz M, Molbak K, Laursen H, et al: Surgery and risk of sporadic Creutzfeldt-Jakob disease in Denmark and Sweden: registry-based case-control studies. Neuroepidemiology 2008; 31: 229-240.
10. de Pedro-Cuesta J, Mahillo-Fernandez I, Rabano A, Calero M, Cruz M, Siden A, et al: Nosocomial transmission of sporadic Creutzfeldt-Jakob disease: results from a risk-based assessment of surgical interventions. J Neurol Neurosurg Psychiatry 2011; 82: 204-212.
11. Ward HJ, Knight RS: Surgery and risk of sporadic Creutzfeldt-Jakob disease. Neuroepidemiology 2008; 31: 241-242.
12. Ruiz-Tovar M, de Pedro-Cuesta J, Smith A, Alonso C, Calero M, Pocchiari M, et al: Review of guidelines for prevention of Creutzfeldt-Jakob disease transmission in medical settings in EU member states and Norway. Stockholm, ECDC Technical Report, 2011. http://www.ecdc.europa.eu/en/publications/Publications/ 1106-TER-Review-of-guidelines-for-prevention-of%20 CJD.pdf (cited 2011 June 21).
13. Kondo K, Kuroiwa Y: A case control study of Creutzfeldt-Jakob disease: association with physical injuries. Ann Neurol 1982; 11: 377-381. (Pubitemid 12133697)
14. Davanipour Z, Alter M, Sobel E, Asher D, Gajdusek DC: Creutzfeldt-Jakob disease: possible medical risk factors. Neurology 1985; 35: 1483-1486. (Pubitemid 15242428)
15. Harries-Jones R, Knight RS, Will RG, Cousens SN, Smith PG, Matthews WB: Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry 1988; 51: 1113-1119.
16. Puopolo M, Ladogana A, Vetrugno V, Pocchiari M: Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases. Transfusion 2011; 51: 1556-1566.
17. Molesworth AM, Mackenzie J, Everington D, Knight RS, Will RG: Sporadic Creutzfeldt-Jakob disease and risk of blood transfusion in the United Kingdom. Transfusion 2011; 51: 1872-1873.
18. Abrams JY, Schonberger LB, Belay ED, Maddox RA, Leschek EW, Mills JL, et al: Lower risk of Creutzfeldt-Jakob disease in pituitary growth hormone recipients initiating treatment after 1977. J Clin Endocrinol Metab 2011; 96:E1666-E1669.
19. Linsell L, Cousens SN, Smith PG, Knight RS, Zeidler M, Stewart G, et al: A case-control study of sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of clustering. Neurology 2004; 63: 2077-2083. (Pubitemid 39636255)
20. Rabano A, de Pedro-Cuesta J, Molbak K, Siden A, Calero M, Laursen H: Tissue classification for the epidemiological assessment of surgical transmission of sporadic Creutzfeldt-Jakob disease. A proposal on hypothetical risk levels. BMC Public Health 2005; 5: 9.
21. Swerdlow AJ, Higgins CD, Adlard P, Jones ME, Preece MA: Creutzfeldt-Jakob disease in United Kingdom patients treated with human pituitary growth hormone. Neurology 2003; 61: 783-791. (Pubitemid 37174473)
22. Wientjens DP, Rikken B, Wit JM, Hofman A, Stricker BH: A nationwide cohort study on Creutzfeldt-Jakob disease among human growth hormone recipients. Neuroepidemiology 2000; 19: 201-205. (Pubitemid 30428847)
23. Buchanan CR, Preece MA, Milner RD: Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. BMJ 1991; 302: 824-828.
24. Mills JL, Fradkin JE, Schonberger LB, Gunn W, Thomson RA, Piper J, et al: Status report on the US human growth hormone recipient follow-up study. Horm Res 1990; 33: 116-119.
25. Nakamura Y, Aso E, Yanagawa H: Relative risk of Creutzfeldt-Jakob disease with cadaveric dura transplantation in Japan. Neurology 1999; 53: 218-220. (Pubitemid 29329677)
26. Esmonde TF, Will RG, Slattery JM, Knight RS, Harries-Jones R, de Silva R, et al: Creutzfeldt-Jakob disease and blood transfusion. Lancet 1993; 341: 205-207. (Pubitemid 23048084)
27. van Duijn CM, Delasnerie-Laupretre N, Masullo C, Zerr I, de Silva R, Wientjens DP, et al: Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD). Lancet 1998; 351: 1081-1085. (Pubitemid 28162198)
28. Zerr I, Brandel JP, Masullo C, Wientjens DP, de Silva R, Zeidler M, et al: European surveillance on Creutzfeldt-Jakob disease: a casecontrol study for medical risk factors. J Clin Epidemiol 2000; 53: 747-754. (Pubitemid 30609629)
29. Laske C, Gefeller O, Pfahlberg A, Zerr I, Schroter A, Poser S: The effect of stress on the onset and progression of Creutzfeldt-Jakob disease: results of a German pilot case-control study. Eur J Epidemiol 1999; 15: 631-635. (Pubitemid 29474434)
30. Nakamura Y, Oki I, Tanihara S, Ojima T, Yanagawa H, Kitamoto T, et al: A case-control study of Creutzfeldt-Jakob disease in Japan: transplantation of cadaveric dura mater was a risk factor. J Epidemiol 2000; 10: 399-402.
31. Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL: Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a casecontrol study. Lancet 1999; 353: 693-697. (Pubitemid 29103801)
32. Ward HJ, Everington D, Croes EA, Alperovitch A, Delasnerie-Laupretre N, Zerr I, et al: Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls. Neurology 2002; 59: 543-548. (Pubitemid 34919987)
33. S-Juan P, Ward HJ, de Silva R, Knight RS, Will RG: Ophthalmic surgery and Creutzfeldt-Jakob disease. Br J Ophthalmol 2004; 88: 446-449. (Pubitemid 38437855)
34. Ward HJ, Everington D, Cousens SN, Smith-Bathgate B, Gillies M, Murray K, et al: Risk factors for sporadic Creutzfeldt-Jakob disease. Ann Neurol 2008; 63: 347-354. (Pubitemid 351499864)
35. Hamaguchi T, Noguchi-Shinohara M, Nozaki I, Nakamura Y, Sato T, Kitamoto T, et al: Medical procedures and risk for sporadic Creutzfeldt-Jakob disease, Japan, 1999-2008. Emerg Infect Dis 2009; 15: 265-271.
36. Ruegger J, Stoeck K, Amsler L, Blaettler T, Zwahlen M, Aguzzi A, et al: A case-control study of sporadic Creutzfeldt-Jakob disease in Switzerland: analysis of potential risk factors with regard to an increased CJD incidence in the years 2001-2004. BMC Public Health 2009; 9: 18.
37. Dorsey K, Zou S, Schonberger LB, Sullivan M, Kessler D, Notari E, et al: Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study. Transfusion 2009; 49: 977-984.
38. Zaman SM, Hill FG, Palmer B, Millar CM, Bone A, Molesworth AM, et al: The risk of variant Creutzfeldt-Jakob disease among UK patients with bleeding disorders, known to have received potentially contaminated plasma products. Haemophilia 2011; 17: 931-937.
39. Rothman KJ, Greenland S, Lash TL: Casecontrol studies; in Modern Epidemiology, ed 3. Philadelphia, Lippincott Williams & Wilkins, 2008, pp 111-127.
40. Wacholder S: The case-control study as data missing by design: estimating risk differences. Epidemiology 1996; 7: 144-150. (Pubitemid 26068046)
41. Weightman A, Ellis S, Cullum A, Sander L, Turley R: Grading evidence and recommendations for public health interventions: developing and piloting a framework. Health Development Agency 2005, March 31. http://www.nice.org.uk/ download.aspx?o=503421 (cited 2010 May 11).
42. Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al: Going from evidence to recommendations. BMJ 2008; 336: 1049-1051.
43. Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, et al: Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 2005; 64: 1586-1591. (Pubitemid 40617696)
44. Josephs KA, Ahlskog JE, Parisi JE, Boeve BF, Crum BA, Giannini C, et al: Rapidly progressive neurodegenerative dementias. Arch Neurol 2009; 66: 201-207.
45. Schmidt C, Wolff M, Weitz M, Bartlau T, Korth C, Zerr I: Rapidly progressive Alzheimer disease. Arch Neurol 2011; 68: 1124-1130.
46. Glover JA: The incidence of tonsillectomy in school children. 1938. Int J Epidemiol 2008; 37: 9-19.
47. Klemetti A, Saxen L: Prospective versus retrospective approach in the search for environmental causes of malformations. Am J Public Health Nations Health 1967; 57: 2071-2075.
48. Gravenor MB, Stallard N, Curnow R, McLean AR: Repeated challenge with prion disease: the risk of infection and impact on incubation period. Proc Natl Acad Sci USA 2003; 100: 10960-10965. (Pubitemid 37140135)
49. Boelle PY, Cesbron JY, Valleron AJ: Epidemiological evidence of higher susceptibility to vCJD in the young. BMC Infect Dis 2004; 4: 26.
50. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens SN, Mackenzie J, et al: Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363: 417-421. (Pubitemid 38210057)
51. Beeri MS, Rapp M, Silverman JM, Schmeidler J, Grossman HT, Fallon JT, et al: Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Neurology 2006; 66: 1399-1404. (Pubitemid 43739650)
52. Lee TA, Wolozin B, Weiss KB, Bednar MM: Assessment of the emergence of Alzheimer's disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty. J Alzheimers Dis 2005; 7: 319-324. (Pubitemid 41206944)